adplus-dvertising
Connect with us

Business

As U.S., U.K. plan to roll out vaccines in December, Canada largely silent on distribution – CBC.ca

Published

 on


Two of Canada’s closest allies have laid out plans to distribute new vaccines against the deadly novel coronavirus, with the first shots expected to be delivered in December.

Canada, meanwhile, has been largely silent on how promising vaccine candidates will be distributed here after Health Canada regulators give them the green light — providing few, if any, details beyond a promise to work with the provinces and territories and buy cold storage.

The federal government has procured some 358 million doses from seven companies — an insurance policy against the possibility that some of the vaccines in development prove to be ineffective in clinical trials. Little is known about how and when the vaccines will be made available, however.

“Our government has worked hard to secure tens of millions of doses, so we’re prepared once a safe, effective vaccine is ready for Canadians,” Prime Minister Justin Trudeau said today, adding that it’s “premature” to say when communities will have access to the vaccines.

Trudeau said Canada — unlike the U.S., the United Kingdom and Germany — doesn’t have any domestic vaccine manufacturing capacity, which means it could be a while yet before Canadians get a dose. “We’re looking forward to being able to vaccinate Canadians in the coming months,” he said.

WATCH: Trudeau says lack of Canadian manufacturing capacity to blame for vaccine challenges

Prime Minister Justin Trudeau spoke to reporters outside his home in Ottawa on Tuesday 1:59

Dr. Moncef Slaoui is the chief scientific adviser to Operation Warp Speed — the U.S. mission to develop a vaccine, manufacture it in large quantities and push it out into communities. The U.S. Food and Drug Administration (FDA) is set to meet on Dec. 10 to make a final decision on Pfizer’s highly-effective vaccine and Slaoui said inoculations will begin immediately.

“Our plan is to be able to ship vaccines to the immunization sites within 24 hours from the approval,” Slaoui said in an interview with CNN.

“I would expect maybe on day two after approval, on Dec. 11 or Dec 12, hopefully, the first people will be immunized across the U.S., across all states, in all areas where the state departments of health have told us to deliver the vaccine.”

20 million Americans to be vaccinated in December

Slaoui said as many as 20 million Americans will be vaccinated in December, and 30 million more Americans will be vaccinated in every subsequent month.

Since October, Pfizer has been manufacturing hundreds of thousands of doses each week — even though it hasn’t yet received regulatory approval. The company hopes to make 100 million doses available this year and another 1.3 billion in 2021. Each patient will need two doses of Pfizer’s vaccine.

Dr. Moncef Slaoui, the chief scientific adviser to Operation Warp Speed, says 20 million Americans will be vaccinated in December. (Evan Vucci/AP Photo)

The National Health Service (NHS) in England has designated 1,250 local health clinics as vaccine sites where, starting as early as Dec. 1, staff will be on hand to administer the vaccine over 12-hour shifts, seven days a week. Each clinic site is expected to inoculate at least 975 people per week.

The NHS already has started booking vaccine appointments, designating blocks to priority groups. Vaccinations in the U.K. will start with older adult residents in long-term care homes and care home workers, all those 80 years of age and over and health and social care workers, before being offered to those aged 75 years or younger.

“I have tasked the NHS with being ready from any date from Dec. 1. The logistics are complex, the uncertainties are real and the scale of the job is vast, but I know that the NHS, brilliantly assisted by the armed services, will be up to the task,” Matt Hancock, the U.K.’s health secretary, told Parliament last week.

In May, the U.S. tapped a retired four-star army general, Gen. Gustave Perna, to coordinate the distribution efforts — a massive task that will see millions of doses of the vaccine deployed to every state starting next month, through a partnership with U.S. drug distribution giant McKesson.

Perna is a former commanding general for the U.S. Army Materiel Command, which manages the Army’s global supply chain, making him uniquely qualified to run such a complicated distribution network.

“The country’s existing public health infrastructure is well tested — we see evidence every fall when Americans receive the flu vaccine in large numbers. But these are not normal times,” Perna said in a media statement. “Leveraging our military planning and logistics capability and combining that with proven methods will allow existing systems to scale quickly to get the vaccine to the American people.”

Operation Warp Speed will also distribute ancillary kits with all the required supplies to administer COVID-19 vaccines, such as needles, syringes, alcohol pads and limited personal protective equipment. (Supplied by the U.S. Department of Defense)

More than 1 million standard kits — which would cover 100 million vaccine doses — have been assembled by Operation Warp Speed.

The military and McKesson will distribute vaccines along with ancillary kits with all the required supplies to administer them, such as needles, syringes, alcohol pads and limited personal protective equipment.

Pfizer has an assembly centre in Kalamazoo, Michigan, and the drug manufacturer plans to use private shipping companies such as UPS and FedEx to deliver vaccines to hospitals and vaccination sites within hours.

Watch: Bains and Anand explain how Ottawa is developing Canadian vaccine production.:

Federal Industry Minister Navdeep Bains and Procurement Minister Anita Anand spoke with reporters on Tuesday. 1:48

While Operation Warp Speed will deliver vaccine shipments, it will be up to the states, territories and major metropolitan areas to further define where the doses ultimately go. All 50 states have submitted COVID-19 distribution plans to the U.S. Centers for Disease Control (CDC).

The CDC has flowed more than $300 million to the states to fine-tune the deployment process and, last month, the agency publicly released a 75-page playbook detailing everything from vaccine provider recruitment and enrolment guidelines, vaccine storage and handling tips to information on which groups should be first in line for a shot.

The CDC also has signed agreements with major U.S. pharmacy chains CVS and Walgreens to assist with on-site vaccinations at long-term care facilities (LTCs), which have been especially hard hit by the pandemic.

Operation Warp Speed chief operating officer Gen. Gustave Perna, left, and Stefano Pessina, right, the CEO of Walgreens Boots Alliance, meet to discuss COVID-19 vaccine distribution plans. The CDC has signed agreements with major U.S. pharmacy chains CVS and Walgreens to assist with on-site vaccinations at long-term care facilities. (Supplied by the Office of the Secretary of Defense Public Affairs)

Germany also could start administering shots of COVID-19 vaccines as soon as next month, Jens Spahn, the country’s health minister, said Sunday.

Spahn said he has asked Germany’s federal states to have their vaccination centres ready by mid-December. “I’d rather have a ready-to-go immunization centre that remains inactive for several days than a licensed vaccine that cannot be administered,” the minister said, adding that vulnerable persons, such as the elderly, would be treated first.

Canadian officials working ‘around the clock’: health minister

The Canadian federal government, by comparison, has said little publicly about what it has planned for vaccine distribution.

The scientists at the National Advisory Committee on Immunization (NACI) recently issued preliminary guidance on who should get priority for a vaccine.

Public Services and Procurement Minister Anita Anand announced last week the government has plans to purchase more than 100 new freezers to help store incoming COVID-19 vaccines from Pfizer but also Moderna.

When asked Tuesday why Canada seems to be further behind in the race to distribute vaccines, Health Minister Patty Hajdu said the whole process is complicated and Health Canada hasn’t yet approved a vaccine candidate.

“I can’t speak to allied countries’ regulatory processes. I can just speak to mine,” she said.

Hajdu said the health department is “working hand in glove” with procurement officials to distribute a vaccine, once Canada gets one.

“All of our departments are working right now, around the clock actually, on making sure we have a concrete plan with the provinces and territories, that we are ready to deploy the vaccines as soon as they arrive on Canadian soil,” she said.

Let’s block ads! (Why?)

728x90x4

Source link

Continue Reading

Business

Transat AT reports $39.9M Q3 loss compared with $57.3M profit a year earlier

Published

 on

 

MONTREAL – Travel company Transat AT Inc. reported a loss in its latest quarter compared with a profit a year earlier as its revenue edged lower.

The parent company of Air Transat says it lost $39.9 million or $1.03 per diluted share in its quarter ended July 31.

The result compared with a profit of $57.3 million or $1.49 per diluted share a year earlier.

Revenue in what was the company’s third quarter totalled $736.2 million, down from $746.3 million in the same quarter last year.

On an adjusted basis, Transat says it lost $1.10 per share in its latest quarter compared with an adjusted profit of $1.10 per share a year earlier.

Transat chief executive Annick Guérard says demand for leisure travel remains healthy, as evidenced by higher traffic, but consumers are increasingly price conscious given the current economic uncertainty.

This report by The Canadian Press was first published Sept. 12, 2024.

Companies in this story: (TSX:TRZ)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

Dollarama keeping an eye on competitors as Loblaw launches new ultra-discount chain

Published

 on

 

Dollarama Inc.’s food aisles may have expanded far beyond sweet treats or piles of gum by the checkout counter in recent years, but its chief executive maintains his company is “not in the grocery business,” even if it’s keeping an eye on the sector.

“It’s just one small part of our store,” Neil Rossy told analysts on a Wednesday call, where he was questioned about the company’s food merchandise and rivals playing in the same space.

“We will keep an eye on all retailers — like all retailers keep an eye on us — to make sure that we’re competitive and we understand what’s out there.”

Over the last decade and as consumers have more recently sought deals, Dollarama’s food merchandise has expanded to include bread and pantry staples like cereal, rice and pasta sold at prices on par or below supermarkets.

However, the competition in the discount segment of the market Dollarama operates in intensified recently when the country’s biggest grocery chain began piloting a new ultra-discount store.

The No Name stores being tested by Loblaw Cos. Ltd. in Windsor, St. Catharines and Brockville, Ont., are billed as 20 per cent cheaper than discount retail competitors including No Frills. The grocery giant is able to offer such cost savings by relying on a smaller store footprint, fewer chilled products and a hearty range of No Name merchandise.

Though Rossy brushed off notions that his company is a supermarket challenger, grocers aren’t off his radar.

“All retailers in Canada are realistic about the fact that everyone is everyone’s competition on any given item or category,” he said.

Rossy declined to reveal how much of the chain’s sales would overlap with Loblaw or the food category, arguing the vast variety of items Dollarama sells is its strength rather than its grocery products alone.

“What makes Dollarama Dollarama is a very wide assortment of different departments that somewhat represent the old five-and-dime local convenience store,” he said.

The breadth of Dollarama’s offerings helped carry the company to a second-quarter profit of $285.9 million, up from $245.8 million in the same quarter last year as its sales rose 7.4 per cent.

The retailer said Wednesday the profit amounted to $1.02 per diluted share for the 13-week period ended July 28, up from 86 cents per diluted share a year earlier.

The period the quarter covers includes the start of summer, when Rossy said the weather was “terrible.”

“The weather got slightly better towards the end of the summer and our sales certainly increased, but not enough to make up for the season’s horrible start,” he said.

Sales totalled $1.56 billion for the quarter, up from $1.46 billion in the same quarter last year.

Comparable store sales, a key metric for retailers, increased 4.7 per cent, while the average transaction was down2.2 per cent and traffic was up seven per cent, RBC analyst Irene Nattel pointed out.

She told investors in a note that the numbers reflect “solid demand as cautious consumers focus on core consumables and everyday essentials.”

Analysts have attributed such behaviour to interest rates that have been slow to drop and high prices of key consumer goods, which are weighing on household budgets.

To cope, many Canadians have spent more time seeking deals, trading down to more affordable brands and forgoing small luxuries they would treat themselves to in better economic times.

“When people feel squeezed, they tend to shy away from discretionary, focus on the basics,” Rossy said. “When people are feeling good about their wallet, they tend to be more lax about the basics and more willing to spend on discretionary.”

The current economic situation has drawn in not just the average Canadian looking to save a buck or two, but also wealthier consumers.

“When the entire economy is feeling slightly squeezed, we get more consumers who might not have to or want to shop at a Dollarama generally or who enjoy shopping at a Dollarama but have the luxury of not having to worry about the price in some other store that they happen to be standing in that has those goods,” Rossy said.

“Well, when times are tougher, they’ll consider the extra five minutes to go to the store next door.”

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:DOL)

Source link

Continue Reading

Business

U.S. regulator fines TD Bank US$28M for faulty consumer reports

Published

 on

 

TORONTO – The U.S. Consumer Financial Protection Bureau has ordered TD Bank Group to pay US$28 million for repeatedly sharing inaccurate, negative information about its customers to consumer reporting companies.

The agency says TD has to pay US$7.76 million in total to tens of thousands of victims of its illegal actions, along with a US$20 million civil penalty.

It says TD shared information that contained systemic errors about credit card and bank deposit accounts to consumer reporting companies, which can include credit reports as well as screening reports for tenants and employees and other background checks.

CFPB director Rohit Chopra says in a statement that TD threatened the consumer reports of customers with fraudulent information then “barely lifted a finger to fix it,” and that regulators will need to “focus major attention” on TD Bank to change its course.

TD says in a statement it self-identified these issues and proactively worked to improve its practices, and that it is committed to delivering on its responsibilities to its customers.

The bank also faces scrutiny in the U.S. over its anti-money laundering program where it expects to pay more than US$3 billion in monetary penalties to resolve.

This report by The Canadian Press was first published Sept. 11, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending